Table 3.
Obesity measurements of 201 ccRCC patients, stratified by sex
| Total (n = 201) | Male (n = 150; 75%) | Female (n = 51; 25%) | p value* | |
|---|---|---|---|---|
| BMI category, n (%) | 0.083 | |||
| <25 | 34 (16.9) | 20 (13.3) | 14 (27.5) | |
| 25–<30 | 68 (33.8) | 53 (35.3) | 15 (29.4) | |
| ≥ 30 | 99 (49.3) | 77 (51.3) | 22 (43.1) | |
| Median TFA (range) | 48423 (11697–109671) | 48202 (11697–104010) | 49888 (13433–109671) | 0.807 |
| Median SFA (range) | 27913 (7377–79789) | 26418 (7377–79789) | 32765 (10685–78819) | 0.010 |
| Median VFA (range) | 19009 (2748–42375) | 21862 (3075–42375) | 15649 (2748–35898) | <0.001 |
| Median VFA% (range) | 39.2 (14.9–98.6) | 41.9 (21.0–68.9) | 27.7 (14.9–98.6) | <0.001 |
*
p value from Fisher’s exact test when categorical, and Wilcoxon test when continuous; ccRCC: clear cell renal cell carcinoma; BMI: body mass index; TFA: total fat area; SFA: subcutaneous fat area; VFA: visceral fat area.